Abstracts Archive - Page 2415 of 2425 - ACR Meeting Abstracts

Abstract Number: 96 • 2012 ACR/ARHP Annual Meeting
Quality of Care: Reference and Counter Reference From Family Physicians and Rheumatologists’ perspectives– A Pilot Study
Thiago D. Baumgratz¹, Raphael Battisti¹, Mirella Cuziol², Ana Carolina Reiff Janini², R.A. Levy³ and Mirhelen M. Abreu⁴, ¹Medical Student at Universidade Federal de São Carlos, São Carlos, Brazil, ²Medicine, Medical Student at Universidade Federal de São Carlos, São Carlos, Brazil, ³Hospital Universitário Pedro Ernesto, Rio de Janeiro, Brazil, ⁴Universidade Federal de São Carlos, São Carlos SP, Brazil
Background/Purpose: We delineated family physicians' and rheumatologists’ point of view when primary care is facing cases of rheumatic diseases. We also tried to identify barriers…
Abstract Number: 97 • 2012 ACR/ARHP Annual Meeting
Systematic Review of Explanatory and Predictive Models in Rheumatology: Lack of Adhearance to Methodologic Standards
Daniel A. Albert, Medicine/Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Background/Purpose: Prognostic and explanatory models are frequently utilized in clinical medicine to assist in judgments about diagnosis, prognosis, and treatment options. I surveyed predictive and…
Abstract Number: 98 • 2012 ACR/ARHP Annual Meeting
How to Assess Risks for Pulmonary Infection in Patients Receiving Immunosuppressive Treatment for Rheumatic Diseases? A Report From a Large-Scale Prospective Cohort Study
Hayato Yamazaki¹, Ryoko Sakai¹, Ryuji Koike², Yasunari Miyazaki³, Michi Tanaka¹, Toshihiro Nanki¹, Kaori Watanabe¹, Shinsuke Yasuda⁴, Takashi Kurita⁵, Yuko Kaneko⁶, Yoshiya Tanaka⁷, Yasuhiko Nishioka⁸, Yoshinari Takasaki⁹, Kenji Nagasaka¹⁰, Koichi Amano¹¹, Shigeto Tohma¹², Makoto Dohi¹³, Takahiko Sugihara¹⁴, Haruhito Sugiyama¹⁵, Yasushi Kawaguchi¹⁶, Naohiko Inase¹⁷, Sae Ochi¹⁸, Hiroyuki Hagiyama¹⁹, Nobuyuki Miyasaka²⁰ and Masayoshi Harigai²¹, ¹Department of Pharmacovigilance, Tokyo Medical and Dental University, Tokyo, Japan, ²Clinical Research Center, Tokyo Medical and Dental University, Tokyo, Japan, ³Department of Integrated Pulmonology, Tokyo Medical and Dental University, Tokyo, Japan, ⁴Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, ⁵Department of Medicine II, Hokkaido University, Sapporo, Japan, ⁶Dept of Internal Medicine, Keio Univ School of Medicine, Tokyo, Japan, ⁷The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, ⁸Department of Respiratory Medicine & Rheumotology, The Univeristy of Tokushima Graduate School, Tokushima, Japan, ⁹Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, ¹⁰Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan, ¹¹Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Saitama, Japan, ¹²Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan, ¹³Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, ¹⁴Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, ¹⁵Division of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan, ¹⁶Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ¹⁷Dept of Integrated Pulmonology, Tokyo Medical and Dental University, Tokyo, Japan, ¹⁸Department of Rheumatology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan, ¹⁹Department of Rheumatology, Yokohama-city Bay Red Cross Hospital, Yokohama, Japan, ²⁰Department of Medicine and Rheumatology and Global Center of Excellence Program, Tokyo Medical and Dental University, Tokyo, Japan, ²¹Dept of Pharmacovigilance, Tokyo Medical and Dental University, Tokyo, Japan
Background/Purpose: Patients with rheumatic diseases given immunosuppressive therapy are susceptible to various types of infections, especially pulmonary infections that affect their vital prognosis. The aim…
Abstract Number: 99 • 2012 ACR/ARHP Annual Meeting
Cancer Iincidence and Type of Malignancy in Rrheumatologic Ddiseases in Korea: Head-to-Head Comparison
Sung Hae Chang¹, Jin Kyun Park² and Eun Bong Lee¹, ¹Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, ²Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, South Korea
Cancer Incidence in Rheumatic Diseases: Head-to-Head Comparison. Background/Purpose: Rheumatic diseases (RD) are associated with increased risk of developing cancer. However, it remains to define, if…
Abstract Number: 100 • 2012 ACR/ARHP Annual Meeting
Further Evidence On Biased Cancer Risk Estimation in Studies Comparing A Subpopulation to the General Population
Koray Tascilar¹ and Hasan Yazici², ¹University of Istanbul, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey, ²Istanbul University, Cerrahpasa Medical School, Istanbul University, Cerrahpasa Medical School, Rheumatology, Istanbul, Turkey
Background/Purpose: We had previously proposed a selection bias in studies estimating cancer risk in patients with rheumatoid arthritis (RA) stemming from the comparison of a…
Abstract Number: 101 • 2012 ACR/ARHP Annual Meeting
Kidney Function and the Risk of Incident Gout in A Population-Based Cohort of Adults: Atherosclerosis Risk in Communities Study
Mara McAdams DeMarco¹, Anna Kottgen², Andrew Law³, Janet W. Maynard⁴, Josef Coresh¹ and Alan N. Baer⁵, ¹Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, ²Renal Division, University Hospital Freiburg, Freiburg, Germany, ³Epidemiology, Johns Hopkins, Baltimore, MD, ⁴Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: The 1-year cumulative incidence of gout in patients with new onset end stage renal disease is 5% and rises to 15% by 5 years,…
Abstract Number: 102 • 2012 ACR/ARHP Annual Meeting
Sonographic Assessment of Normal Peripheral Joints: Evaluation According to Demographics Parameters
Flavia S. Machado¹, Rita N.V. Furtado¹, Rogerio D. Takahashi², Ana Leticia P. de Buosi¹ and Jamil Natour¹, ¹Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, ²Radiology, Universidade Federal de São Paulo, São Paulo, Brazil
Background/Purpose: to describe quantitative and semiquantitative joint ultrasound measurements in healthy people and compare them among different demographic parameters. Methods: Bilateral ultrasound measurement of small,…
Abstract Number: 103 • 2012 ACR/ARHP Annual Meeting
A Pragmatic Musculoskeletal Ultrasound Screening Protocol Does Not Add to a Predictive Algorithm for Persistent Inflammatory Arthritis in a UK Early Arthritis Clinic
Arthur G. Pratt¹, Alice R. Lorenzi², Gillian Wilson², Philip N. Platt³ and John D. Isaacs¹, ¹Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, ²Musculoskeletal Directorate, Freeman Hospital, Newcastle upon Tyne, United Kingdom, ³Rheumatology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
Background/Purpose: Analyses of large clinical datasets from early arthritis cohorts permit the development of algorithms that may be used for outcome prediction in individual patients.…
Abstract Number: 104 • 2012 ACR/ARHP Annual Meeting
The Usefulness of A NEW Musculoskeletal ULTRASOUND Scoring System of the Hands and Wrist Joints (US10) for Evaluation of EARLY Rheumatoid Arthritis Patients
Karine R. Luz, Rita N.V. Furtado, Marcelo M. Pinheiro, Giovanna S. Petterle and Jamil Natour, Rheumatology Division, Universidade Federal de São Paulo, São Paulo, Brazil
Background/Purpose: Ultrasound (US) can be a useful tool for monitoring rheumatoid arthritis (RA). However, it can be time consuming when applied to too many joints…
Abstract Number: 105 • 2012 ACR/ARHP Annual Meeting
Combined Synovial and Structural Ultrasound Score for the Diagnosis of RA
Gary A. Kunkel¹, Grant W. Cannon² and Daniel O. Clegg³, ¹Div of Rheumatology, George Wahlen Veterans Affairs Medical Center, Salt Lake City, UT, ²Division of Rheumatology, George E. Wahlen VA Medical Center, Salt Lake City, UT, ³Division of Rheumatology, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, UT
Background/Purpose: Current ultrasonographic scoring systems used to assess the degree of finger joint synovitis in rheumatoid arthritis (RA) are not designed for distinguishing healthy or…
Abstract Number: 106 • 2012 ACR/ARHP Annual Meeting
Development of a 6 Joint Simplified Ultrasonographic Score to Assess Disease Activity in Patients with Rheumatoid Arthritis
Tomas Cazenave¹, Christian A. Waimann², Gustavo Citera¹ and Marcos G. Rosemffet¹, ¹Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
Background/Purpose: Ultrasound has become a routinely available bedside method for the evaluation of patients with Rheumatoid Arthritis (RA). However, it is time consuming, making it…
Abstract Number: 66 • 2012 ACR/ARHP Annual Meeting
Pre-Rheumatoid Arthritis (pre-RA) Subjects Had a Minority Excess with Clearly Low Serum Cortisol Levels and Females Had Lower Mean Androstenedione Levels Than Control (CN) Cohorts in Analysis of a Large Panel of Serum Steroids and Pituitary Hormones
Alfonse T. Masi¹, Kevin B. Elmore¹, Azeem A. Rehman¹, Jean C. Aldag¹ and Robert T. Chatterton², ¹Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, ²Obstetrics and Gynecology and Physiology, Northwestern University, Chicago, IL
Background/Purpose: Low serum DHEAS may predispose a minority of premenopausal women to RA. A comprehensive panel of serum steroids, their related product-to-precursor (P-P) ratios and…
Abstract Number: 67 • 2012 ACR/ARHP Annual Meeting
Increased Prevalence of Hypothyroidism Preceding Rheumatoid Arthritis – an Epidemiological Study
Anne M. Kerola¹, Tuomo Nieminen², Markku J. Kauppi³, Hannu Kautiainen⁴, Kari Puolakka⁵, Lauri J. Virta⁶ and Tuomas Kerola³, ¹Medical School, University of Helsinki, Helsinki, Finland, ²Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland, ³Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland, ⁴Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland, ⁵Department of Medicine, South Karelia Central Hospital, Lappeenranta, Finland, ⁶Research Department, the Social Insurance Institution, Turku, Finland
Background/Purpose: Rheumatoid arthritis (RA) is associated with a wide set of comorbidities, including several autoimmune diseases such as autoimmune thyroiditis, which is a common cause…
Abstract Number: 68 • 2012 ACR/ARHP Annual Meeting
Cardiovascular Comorbidities Antedating the Diagnosis of Rheumatoid Arthritis
Anne M. Kerola¹, Tuomas Kerola², Markku J. Kauppi², Hannu Kautiainen³, Lauri J. Virta⁴, Kari Puolakka⁵ and Tuomo Nieminen⁶, ¹Medical School, University of Helsinki, Helsinki, Finland, ²Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland, ³Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland, ⁴Research Department, the Social Insurance Institution, Turku, Finland, ⁵Department of Medicine, South Karelia Central Hospital, Lappeenranta, Finland, ⁶Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased cardiovascular morbidity. Evidence suggests that RA patients are at an increased risk of…
Abstract Number: 69 • 2012 ACR/ARHP Annual Meeting
The Presence of Asymptomatic Carotid Plaques in Patients with Inflammatory Joint Disease Results in Inadequate Treatment to Lipid Targets in Cardiovascular Disease Prevention
Anne G. Semb¹, Silvia Rollefstad², Inge C. Olsen³, Desiree van der Heijde⁴ and Tore K. Kvien⁵, ¹Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Rhuematology, Diakonhjemmet Hospital, Oslo, Norway, ³Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁵Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
Background/Purpose: The prevalence of asymptomatic carotid plaque (a-CP) is high in patients with inflammatory joint disease (IJD). Patients with a-CP should receive intensive lipid lowering…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].